Windtree Therapeutics Owners

Health Care & Life Sciences » Pharmaceuticals | Windtree Therapeutics Inc.

Windtree Therapeutics Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Broadfin Capital LLC

145,387

3.86%

102,667

0.07%

12/31/2017

Deerfield Management Company LP

71,111

1.89%

58,041

0.01%

12/31/2017

Alyeska Investment Group LP

34,029

0.9%

1,862

12/31/2017

Invesco Capital Management LLC

989

0.03%

09/05/2018

Rockefeller & Co. LLC

603

0.02%

603

08/01/2016

The MassMutual Trust Co., FSB

06/30/2018

View Profile

Address	2600 Kelly Road Warrington Pennsylvania 18976 United States
Employees	-
Website	http://www.windtreetx.com
Updated	07/08/2019
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S.